Tuesday, February 01, 2022 3:57:54 PM
Recent BFRI News
- Biofrontera Inc. Announces Database Lock Of Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC) • GlobeNewswire Inc. • 10/14/2024 02:30:00 PM
- FDA Approves Use of Up To Three Tubes of Biofrontera Inc.’s Ameluz (aminolevulinic acid HCI) Topical Gel, 10% In One Treatment • GlobeNewswire Inc. • 10/07/2024 12:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 08:49:13 PM
- Biofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business Update • GlobeNewswire Inc. • 08/14/2024 08:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:15:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:52:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:52:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:52:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:52:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:52:10 PM
- Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL Lamp • GlobeNewswire Inc. • 06/24/2024 12:30:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/08/2024 10:14:05 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 03/05/2024 10:20:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 02:26:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 02:37:27 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 02/20/2024 12:55:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 10:25:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 09:30:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 09:30:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 09:40:23 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/09/2024 10:01:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 10:27:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 10:25:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 10:00:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 10:00:38 PM
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory Management • Oct 15, 2024 8:21 AM
Kona Gold Beverages, Inc. Announces Strategic Progress and Corporate Evolution • KGKG • Oct 15, 2024 9:00 AM
One World Products Secures First Order for Hemp-Based Reusable Containers, Pioneers Renewable Materials for the Automotive Industry • OWPC • Oct 15, 2024 8:35 AM
CBD Life Sciences, Inc. Announces Strategic MOU with U.S. Armed Forces for Groundbreaking Mushroom Supplement • CBDL • Oct 15, 2024 8:00 AM
HealthLynked Files Non-Provisional Patent for AI-Powered Healthcare Assistant, ARi • HLYK • Oct 15, 2024 8:00 AM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM